PDL BIOPHARMA, INC. Business Finance Contracts & Agreements

86 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Capital Provision Agreement between PDL BioPharma, Inc. and EPPS Investments LLC dated December 11, 2020
Funding Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2021
Description of PDL BioPharma, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
PDL BIOPHARMA, INC.
Biotechnology
2021
Share Purchase Agreement between Bartleby Limited and PDL BioPharma, Inc. dated July 30, 2020
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
PDL BioPharma, Inc. Nonstatutory Inducement Stock Option Agreement Supplement with Participant
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
PDL BioPharma, Inc. Nonstatutory Inducement Stock Option Agreement (Amended 11/15/19)
Warrant Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
PDL BioPharma, Inc. Stock Option Grant Notice Supplement for Equity Incentive Plan Participants
Warrant Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
PDL BioPharma, Inc. Stock Option Agreement Amendment Acknowledgment
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
PDL BioPharma, Inc. Stock Option Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
PDL BioPharma, Inc. Restricted Stock Agreement Amendment Acknowledgment
Equity Distribution Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
PDL BioPharma, Inc. Restricted Stock Agreement (Amended 11/15/19)
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2020
Description of PDL BioPharma, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Stock Agreements
PDL BIOPHARMA, INC.
Biotechnology
2020
Supplemental Indenture for 2.75% Convertible Senior Notes due 2024 between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2019
Indenture Agreement between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A. dated September 17, 2019
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2019
Convertible Notes Exchange Agreement between PDL BioPharma, Inc. and Noteholders (September 2019)
Exchange Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2019
Securities Purchase Agreement between Evofem Biosciences, Inc. and Purchasers dated April 10, 2019
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
CA
2019
Amendment No. 1 to Royalty Purchase and Sale Agreement and Bill of Sale among Depomed, Inc., Depo DR Sub, LLC, and PDL Investment Holdings, LLC
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
2018
Second Amended and Restated Credit Agreement Amendment between the Company and LENSAR, Inc. (December 16, 2016)
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2017
PDL BioPharma, Inc. 2.75% Convertible Senior Note Due 2021 (Global Note)
Note Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Supplemental Indenture for 2.75% Convertible Senior Notes due 2021 between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Indenture Agreement between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A. (2016)
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
PDL BioPharma, Inc. $150,000,000 2.75% Convertible Senior Notes Due 2021 Underwriting Agreement with RBC Capital Markets, LLC
Underwriting Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
PDL BioPharma, Inc. $150,000,000 2.75% Convertible Senior Notes Due 2021 Underwriting Agreement with RBC Capital Markets, LLC
Underwriting Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Noden Pharma DAC Investment and Stockholders’ Agreement with PDL BioPharma, Inc. and Minority Stockholders
Investment Agreements
PDL BIOPHARMA, INC.
Biotechnology
2016
Amendment No. 1 to Revenue Interest Assignment Agreement between ARIAD Pharmaceuticals, Inc. and PDL BioPharma, Inc.
Modification Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Schedule of Amendments to Credit Agreement between PDL BioPharma, Inc. and Direct Flow Medical, Inc.
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2016
Asset Purchase Agreement between Novartis AG, Novartis Pharma AG, Speedel Holding AG, and Noden Pharma DAC for Tekturna® and Rasilez®
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2016
Schedule of Amendments to Credit Agreements between PDL BioPharma, Inc. and Paradigm Spine, LLC and LENSAR, LLC
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2016
Revenue Interest Assignment Agreement between ARIAD Pharmaceuticals, Inc. and PDL BioPharma, Inc. (July 28, 2015)
Assignment Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2015
Amendment Summary to Credit Agreement between PDL BioPharma, Inc. and Direct Flow Medical, Inc. (November 2014)
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
2015
Exchange Agreement Between Tang Capital Partners, LP and PDL BioPharma, Inc. (Unrestricted Stock)
Exchange Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2015
Third Amendment to Amended and Restated Credit Agreement among Wellstat Diagnostics, LLC and PDL BioPharma, Inc.
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2015
Second Amendment to Amended and Restated Credit Agreement between Wellstat Diagnostics, LLC and PDL BioPharma, Inc.
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2015
Amendment No. 1 to Credit Agreement among PDL BioPharma, Inc., Lenders, and Royal Bank of Canada (Feb. 5, 2014)
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
First Amendment to Amended and Restated Credit Agreement among Wellstat Diagnostics, LLC and PDL BioPharma, Inc.
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
Note Purchase Agreement between Accel 300, LLC and PDL BioPharma, Inc. dated April 1, 2014
Note Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2014
Royalty Purchase and Sale Agreement between Depomed, Inc., Depo DR Sub, LLC, and PDL BioPharma, Inc. dated October 18, 2013
Purchase Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2014
Form of Credit Agreement Between PDL BioPharma, Inc. and Borrowers
Credit Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2014
Second Supplemental Indenture to 4.00% Convertible Senior Notes due 2018 between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
Supplemental Indenture for $300,000,000 4.00% Convertible Senior Notes due 2018 between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A.
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014
PDL BioPharma, Inc. Debt Securities Indenture with The Bank of New York Mellon Trust Company, N.A. (2014)
Indenture Agreements
PDL BIOPHARMA, INC.
Biotechnology
NY
2014